Current status of simultaneous liver-kidney transplantation
Hamit Ali1 , Nazli Begum Ozturk2 , N. Emre Herdan1 , Harry Luu1 , Cem Simsek1 , Rumeyza Kazancioglu3 , Ahmet Gurakar1
1Division of Gastroenterology & Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
2Department of Internal Medicine, Beaumont Hospital, Royal Oak, Michigan, USA
3Division of Nephrology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye
2Department of Internal Medicine, Beaumont Hospital, Royal Oak, Michigan, USA
3Division of Nephrology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye
Abstract
Simultaneous liver-kidney transplantation (SLK) is a feasible option for patients with end-stage liver disease and concomitant renal dysfunction or end-stage renal disease. SLK has gained significant attention primarily due to multiple alterations in the allocation criteria over the past two decades. This review aims to summarize the most recent updates and outcomes of the SLK allocation policy, comparing SLK outcomes with those of liver transplantation alone and exploring the implications of donation after cardiac death in SLK procedures.
Keywords: Cirrhosis; liver failure; liver-kidney transplantation; liver trans-plantation renal failure.
